An intravenous injection of a talc-containing drug
Fibrosing interstitial lung disease - An intravenous injection of a talc-containing drug Factor
Last reviewed for CCPS 16 December 2009.
Preliminary questions [40657]
40679 there is some evidence that intravenous injection of a talc-containing drug may be a factor in the development or worsening of the condition under consideration.
41042 the veteran has received an intravenous injection of a talc-containing drug intended for oral use at some time.
41043 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for fibrosing interstitial lung disease.
41044 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for the clinical onset of fibrosing interstitial lung disease.
41046 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and operational service for the clinical onset of fibrosing interstitial lung disease.
or
41047 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and eligible service for the clinical onset of fibrosing interstitial lung disease.
or
the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service. the condition under consideration permanently worsened.41045 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and VEA service for the clinical worsening of fibrosing interstitial lung disease.
41048 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and operational service for the clinical worsening of fibrosing interstitial lung disease.
or
41049 — the veteran has established the causal connection between the intravenous injection of a talc-containing drug intended for oral use and eligible service for the clinical worsening of fibrosing interstitial lung disease.
Clinical onset and operational service [41046]
the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years. the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years within the ten years before the clinical onset of fibrosing interstitial lung disease. the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years within the ten years before the clinical onset of fibrosing interstitial lung disease as a causal result of operational service. the intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years within the ten years before the clinical onset of fibrosing interstitial lung disease, as a causal result of operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.Clinical onset and eligible service [41047]
the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years. the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years within the ten years before the clinical onset of fibrosing interstitial lung disease. the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years within the ten years before the clinical onset of fibrosing interstitial lung disease as a causal result of eligible service. the intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years within the ten years before the clinical onset of fibrosing interstitial lung disease, as a causal result of eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.Clinical worsening and operational service [41048]
the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years. the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years after the clinical onset and within the ten years before the clinical worsening of fibrosing interstitial lung disease. the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years after the clinical onset and within the ten years before the clinical worsening of fibrosing interstitial lung disease as a causal result of operational service. the intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least two years within the ten years before the clinical worsening of fibrosing interstitial lung disease, as a causal result of operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.Clinical worsening and eligible service [41049]
the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years. the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years after the clinical onset and within the ten years before the clinical worsening of fibrosing interstitial lung disease. the veteran received an intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years after the clinical onset and within the ten years before the clinical worsening of fibrosing interstitial lung disease as a causal result of eligible service. the intravenous injection of a talc-containing drug intended for oral use on more days than not for a period of at least three years within the ten years before the clinical worsening of fibrosing interstitial lung disease, as a causal result of eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/fibrosing-interstitial-lung-disease-h010-j60j628j64j684j7/rulebase-fibrosing-interstitial-lung-disease/intravenous-injection-talc-containing-drug